Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03748420 · ClinicalTrials.gov registry record · NA

Medication Adherence Clinical Decision Support

A NA study, sponsored by HealthPartners Institute.

Completed
Registry status
NA
Development phase
5,421
Enrollment target

NCT03748420 is a NA study that has completed, run by HealthPartners Institute. The registered enrollment target is 5,421 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03748420, a NA study, has completed, sponsored by HealthPartners Institute.

COMPLETED
Registry status
NA
Development phase
5,421 participants
Enrollment target

Study Summary

More than 50% of adults treated for diabetes, hypertension, or lipid disorders have suboptimal medication adherence, a prominent barrier to continued improvement in chronic disease care in the United States. Primary care providers (PCPs) often fail to identify medication nonadherence and/or have insufficient time and training to address underlying reasons for it. In this project, we propose a patient-centered and technology-driven strategy to identify patients with adherence issues and apply a team approach to help them achieve evidence-based personalized goals for glucose, blood pressure, or lipids. This intervention extends the use of a widely available clinical decision support (CDS) infrastructure to support a model of care that, for the first time outside of a fully integrated care environment, will integrate pharmacists within the primary care team. The intervention relies on a continuous health informatics loop to do the following: (a) identify high-risk patients with adherence problems at the point of care by expanding the capability of an electronic medical record (EMR)-linked CDS to identify poor adherence to medications; (b) establish and maintain an auto-populating up-to-date registry of patients identified for proactive pharmacist outreach; (c) implement a pharmacist outreach strategy based on an information-motivation-behavioral (IMB) framework recommended by the World Health Organization (WHO) with demonstrated ability to influence adherence across a variety of clinical applications; and (d) coordinate care and adherence information by incorporating pharmacist assessment and action plans into CDS at subsequent office encounters.

Interventions

  • OTHER Adherence Intervention

Trial Details

FieldValue
Enrollment Target 5,421 participants
Start Date 2020-08-19
Est. Completion 2023-01-31
Phase NA

Sponsor

HealthPartners Institute

146 total trials

What the Registry Record Tells You About NCT03748420

The ClinicalTrials.gov registry entry for NCT03748420 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5,421 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Adherence Intervention is the first listed.

NCT03748420 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03748420 about?

NCT03748420 is a clinical study titled "Medication Adherence Clinical Decision Support". More than 50% of adults treated for diabetes, hypertension, or lipid disorders have suboptimal medication adherence, a prominent barrier to continued improvement in chronic disease care in the United States. Primary care providers (PCPs) often fail to identify medication nonadherence and/or have ins...

What is the current status of trial NCT03748420?

This trial is currently completed. It is a NA study. The enrollment target is 5,421 participants. The study started on 2020-08-19. Estimated completion is 2023-01-31.

What interventions are being tested in trial NCT03748420?

The interventions under investigation include: Adherence Intervention (OTHER).

Who is sponsoring clinical trial NCT03748420?

This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.